Corrigendum to “The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells” [Biomed. Pharmacother. 176 (2024) 116892] - 10/06/25

Malgorzata Kucinska ^{a, ⁎} , Julia Pospieszna ^a, Jing Tang ^b, Natalia Lisiak ^c, Ewa Toton ^c, Blazej Rubis ^c, Marek Murias ^a

^a Department of Toxicology, Poznan University of Medical Sciences, 3 Rokietnicka Street, Poznan 60-806, Poland 

^b Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki 00290, Finland 

^c Department of Clinical Chemistry and Molecular Diagnostics, Poznan University of Medical Sciences, 3 Rokietnicka Street, Poznan 60-806, Poland 

^⁎Corresponding author.

Le texte complet de cet article est disponible en PDF.